Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cancer Cell cycle Cell differentiation

Human TACC3 knockout HEK293T cell pellet (ab279097)

Price and availability

670 ₸

Availability

Order now and get it on Tuesday March 09, 2021

Human TACC3 knockout HEK293T cell pellet (ab279097)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

You may also be interested in

Product image
Recombinant Human S100 alpha 6/PRA protein (ab104645)
Product image
Anti-S100 beta antibody - BSA and Azide free (Capture) (ab244761)
Product image
Anti-TRP2/DCT antibody (ab74073)
Product image
Anti-S100 alpha antibody [EPR5251] (ab109384)

Overview

  • Product name

    Human TACC3 knockout HEK293T cell pellet
    See all TACC3 kits
  • Product overview

    Abcam’s knockout cell pellets give you access to native proteins, without the need to culture cells. Our knockout cell pellets are prepared from our single-gene knockout cell lines and provide an additional offering to our cell lysates.

    Cells are snap-frozen to provide high quality pellets that are suitable for extraction with alternative lysis buffers or for preparation of lysates from subcellular fractions. Our knockout cell pellets are suitable for a variety of applications, including PCR, gene expression profiling and DNA library preparation.

  • Parental Cell Line

    HEK293T
  • Organism

    Human
  • Mutation description

    Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 4.
  • Passage number

  • Knockout validation

    Sanger Sequencing, Western Blot (WB)
  • Notes

    Pellet size: 5 million cells/vial.

    This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

  • Tested applications

    Suitable for: WBmore details

Properties

  • Storage instructions

    Store at -80°C. Please refer to protocols.
  • Components 1 kit
    Human TACC3 knockout HEK293T cell pellet 1 vial
    Human wild-type HEK293T cell pellet 1 vial
  • Research areas

    • Cell Biology
    • Cell Cycle
    • Cell differentiation
  • Cell type

    epithelial
  • STR Analysis

    Amelogenin X D5S818: 8, 9 D13S317: 12, 14 D7S820: 11 D16S539: 9, 13 vWA: 16, 19 TH01: 7, 9.3 TPOX: 11 CSF1PO: 11, 12

Target

  • Function

    Plays a role in the microtubule-dependent coupling of the nucleus and the centrosome. Involved in the processes that regulate centrosome-mediated interkinetic nuclear migration (INM) of neural progenitors (By similarity). May be involved in the control of cell growth and differentiation. May contribute to cancer.
  • Sequence similarities

    Belongs to the TACC family.
  • Cellular localization

    Cytoplasm.
  • Target information above from: UniProt accession Q9Y6A5 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Alternative names

    • ERIC 1
    • ERIC-1
    • ERIC1
    • MGC117382
    • MGC133242
    • OTTHUMP00000113796
    • TACC3
    • TACC3_HUMAN
    • Transforming acidic coiled coil containing protein 3
    • Transforming acidic coiled-coil-containing protein 3
    see all

Properties

  • Storage instructions

    Store at -80°C. Please refer to protocols.
  • Components 1 kit
    Human TACC3 knockout HEK293T cell pellet 1 vial
    Human wild-type HEK293T cell pellet 1 vial
  • Research areas

    • Cell Biology
    • Cell Cycle
    • Cell differentiation
  • Cell type

    epithelial
  • STR Analysis

    Amelogenin X D5S818: 8, 9 D13S317: 12, 14 D7S820: 11 D16S539: 9, 13 vWA: 16, 19 TH01: 7, 9.3 TPOX: 11 CSF1PO: 11, 12

Images

  • Western blot - Human TACC3 knockout HEK293T cell pellet (ab279097)
    Western blot - Human TACC3 knockout HEK293T cell pellet (ab279097)

    Lane 1:Wild-type HEK293T cell lysate (20 ug)
    Lane 2:TACC3 knockout HEK293T cell lysate (20 ug)
    Lane 3:HCT116 cell lysate (20 ug)

    ab134154 was shown to specifically react with TACC3 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266316 (knockout cell lysate ab257723) was used. Wild-type and TACC3 knockout samples were subjected to SDS-PAGE. ab134154 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4oC at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

  • Sanger Sequencing - Human TACC3 knockout HEK293T cell pellet (ab279097)
    Sanger Sequencing - Human TACC3 knockout HEK293T cell pellet (ab279097)
    Homozygous: Insertion of the selection cassette in exon 4

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Sarcomeric Alpha Actinin antibody [ACTN2/3293] - BSA and Azide free (ab257330)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.